PUBLICATIONS

 

 

 

  • Ogden A, Garlapati C, Li X, Turaga R, Oprea-Ilies G, Wright N, Bhattarai S, Mittal K, Wetherilt C, Krishnamurti U, Reid M, Jones M, Gupta M, Osan R, Pattni S, Riaz A, Klimov S, Rao A, Cantuaria G, Rida PC, Aneja R. Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancer. Sci Rep. 2017 Feb 20: onlinedownload

 

  • Rakha EA, Green AR. Molecular classification of breast cancer: what the pathologist needs to know. Pathology. 2017 Feb. 49(2):111-119. doi: 10.1016/j.pathol.2016.10.012. Epub 2016 Dec 28. PubMed PMID: 28040199: online

 

  • Wright N, Xia J, Cantuaria G, Klimov S, Jones M, Neema P, Il'yasova D, Krishnamurti U, Li X, Reid MD, Gupta M, Rida PC, Osan R, Aneja R. Distinctions in Breast Tumor Recurrence Patterns Post-Therapy among Racially Distinct Populations. PLoS One. 2017 Jan 13. 12(1):e0170095 PMID: 28085947: onlinedownload

 

  • Wright N, Rida P, Krishnamurti U, Li X, Aneja R. Targeted drugs and diagnostic assays: Companions in the race to combat ethnic disparity. Front Biosci (Landmark Ed). 2017 Jan 1. PMID: 27814611: online download

 

  • Li X, Wetherilt CS, Krishnamurti U, Yang J, Ma Y, Styblo TM, Meisel JL, Peng L, Siddiqui MT, Cohen C, Aneja R. Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple-Negative Breast Cancer. Am J Clin Pathol. 2016 Oct 14. 6(4):496-502. PMID: 27686176: onlinedownload